Wolters Kluwer acquires Open Access publisher
September 30 2022 - 02:45PM
Wolters Kluwer
acquires Open
Access
publisher;Expands Breadth
of Lippincott Journal Portfolio
Waltham, MA, September 30, 2022 – Wolters Kluwer Health
announced today that it has signed and completed an agreement to
acquire IJS Publishing Group
(IJSPG), a
UK-based provider of peer-reviewed medical journals supporting
scientists and authors. The IJSPG portfolio consists of 10 journal
titles, including the International Journal of Surgery (IJS), IJS
Case Reports (IJSCR), and Annals of Medicine and Surgery (AMS).
IJSPG will become part of Health Learning, Research &
Practice (LRP), which offers the Ovid® medical research solution,
publishes over 300 medical journals and hundreds of medical and
nursing books, and produces digital nursing solutions for education
and practice. The acquisition expands the breadth and depth of the
Lippincott journal portfolio with high impact factor,
surgery-related research and strengthens its Open Access position
with several well-established journals accessible in over a dozen
international databases and platforms.
Vikram Savkar,
Senior
Vice
President and General
Manager of the Health LRP Medicine
Segment at Wolters
Kluwer, stated: “Enabling contributors,
clinicians, and researchers to benefit globally from research as
supported by IJS Publishing Group reinforces our commitment to peer
review and Open Access to deliver the best evidence for
decision-making. We are committed to delivering trusted content
that is discoverable and accessible to advance science and the best
care everywhere.”
“For nearly 20 years, IJS Publishing Group has developed
innovative and best-in-class products and services across multiple
market segments. We are excited by Wolters Kluwer’s leadership in
technology-driven research publishing. Its track record of results
growing its Lippincott journal portfolio make it a good fit for our
next phase of growth for IJSPG,” commented Dr. Riaz
Agha, IJSPG
Founder, CEO and
Chairman and Maliha Agha,
IJSPG Director.
In 2021, IJS Publishing Group generated approximately $2 million
in gross revenues. Wolters Kluwer expects the investment to deliver
a return on invested capital (ROIC) above its weighted cost of
capital (8%) within 3-5 years and expects the transaction to have
an immaterial impact on adjusted earnings.
###
About Wolters KluwerWolters Kluwer (Euronext:
WKL) is a global leader in professional information, software
solutions, and services for the clinicians, nurses, accountants,
lawyers, and tax, finance, audit, risk, compliance, and regulatory
sectors. We help our customers make critical decisions every day by
providing expert solutions that combine deep domain knowledge with
advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion.
The group serves customers in over 180 countries, maintains
operations in over 40 countries, and employs approximately 19,800
people worldwide. The company is headquartered in Alphen aan den
Rijn, the Netherlands.
Wolters Kluwer Health provides trusted clinical technology and
evidence-based solutions that engage clinicians, patients,
researchers and students in effective decision-making and outcomes
across healthcare. We support clinical effectiveness, learning and
research, clinical surveillance and compliance, as well as data
solutions. For more information about our solutions, visit
https://www.wolterskluwer.com/en/health and follow us on LinkedIn
and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on
Twitter, Facebook, LinkedIn, and YouTube.
Media |
|
Investors/Analysts |
Gerbert van Genderen
Stort |
André Rebelo |
Meg Geldens |
Corporate
Communications |
Wolters Kluwer
Health |
Investor
Relations |
t + 31 172 641
230 |
t +1 781 392
2411 |
t + 31 172 641
407 |
press@wolterskluwer.com |
andre.rebelo@wolterskluwer.com |
ir@wolterskluwer.com |
Forward-looking Statements and Other Important Legal
Information
This report contains forward-looking statements. These
statements may be identified by words such as “expect”, “should”,
“could”, “shall” and similar expressions. Wolters Kluwer cautions
that such forward-looking statements are qualified by certain risks
and uncertainties that could cause actual results and events to
differ materially from what is contemplated by the forward-looking
statements. Factors which could cause actual results to differ from
these forward-looking statements may include, without limitation:
general economic conditions; conditions in the markets in which
Wolters Kluwer is engaged; behavior of customers, suppliers, and
competitors; technological developments; the implementation and
execution of new ICT systems or outsourcing; and legal, tax, and
regulatory rules affecting Wolters Kluwer’s businesses, as well as
risks related to mergers, acquisitions, and divestments. In
addition, financial risks such as currency movements, interest rate
fluctuations, liquidity, and credit risks could influence future
results. The foregoing list of factors should not be construed as
exhaustive. Wolters Kluwer disclaims any intention or obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
Certain trademarks referenced are owned by Wolters Kluwer N.V.
and its subsidiaries and may be registered in various
countries.
- 22.09.30 Wolters Kluwer acquires Open Access publisher
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
From Mar 2023 to Mar 2024